During the past decade, South Egypt Cancer Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Egypt Cancer Institute" #1 sponsor was "Assiut University" with 11 trials, followed by "South Egypt Cancer Institute" with 7 trials sponsored, "Amany sayed Abass" with 1 trials sponsored, "Shereen Mamdouh" with 1 trials sponsored and "Shimaa Abdalla Ahmed" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Egypt Cancer Institute" #1 collaborator was "Assiut University" with 1 trials as a collaborator and "South Egypt Cancer Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "South Egypt Cancer Institute" are "Postoperative Pain" (3 trials), "Acute Pain" (2 trials), "Abdominal Cancer" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Bone Neoplasms" (1 trials). Many other conditions were trialed in "South Egypt Cancer Institute" in a lesser frequency.

Most popular intervention types in "South Egypt Cancer Institute" are "Procedure" (6 trials), "Drug" (5 trials), "Device" (4 trials), "Diagnostic Test" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Levobupivacaine" (2 trials), "erector spinae block with bupivacaine" (2 trials), "tDCS" (2 trials), "Conventional Cytogenetics Studies" (1 trials) and "Dexmedetomidine infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Egypt Cancer Institute" are 11 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "South Egypt Cancer Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in South Egypt Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South Egypt Cancer Institute, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".